Researchers use an algorithm designed to help robots move to figure out what's possible when designing new molecules in a promising class of pharmaceuticals.
Because we're still not sure exactly what causes dementia, finding a treatment is difficult.
By exploiting the way yeast cells mate, researchers have figured out a quicker, easier way to identify on- and off-target drug interactions.
Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here's where they come from and how they work.
Simpler animal models can give researchers a much clearer picture of human diseases.
With the right investment, an open source drug discovery system might compete with the traditional pharmaceutical industry to deliver the drugs we need.
Understanding how cell signalling goes wrong could lead to the development of precision cancer treatments.